Nearly 80% of Americans believe the COVID-19 vaccines will help combat the pandemic, but 71% are concerned about vaccine side effects. Experts say some side effects are not only normal, but are working.
The majority of the U.S. population is concerned about COVID-19 vaccine side effects and about half are concerned about there being enough supply, according to a new survey recently released by Welltok, a consumer activation company.
Over 60% of the 1,000 consumers surveyed also express the desire for a second dose reminder to ensure they complete the recommended regimen.
Although there are concerns on the Moderna and Pfizer vaccine side effects, most, or 80%, of Americans do feel the vaccines will turn things around. Either way, the mixed feelings prove the world needs to be educated and filled in on all confirmed vaccine benefits and side effects.
“Early COVID-19 vaccination trends illustrate the need for greater education around the potential public health benefit. To achieve herd immunity will require getting the ‘moveable middle’ to take action,” said April Gill, chief strategy officer for Welltok. “We are leveraging healthcare and non-healthcare data to predict who may be on the fence about getting the vaccine – and why – to develop and deliver fact-based, personalized messages to overcome vaccine hesitancy.”
To get better idea of the general population’s perceptions about the COVID-19 vaccines, Welltok partnered with research firm Ipsos to conduct the nationwide survey.
Key findings from the new This Is Your Shot: Get Your COVID-19 Vaccine Communications Right report include:
Chief Health Officer at Starkey Hearing in Minneapolis and Medical Expert, Archelle Georgiou, however, has some light to shed on vaccine side effects. Georgiou recently shared with local Minneapolis news that many of these side effects are normal and the vaccine is doing what it should be.
According to a Pfizer FDA document, about 84% of the patients in the drug's clinical trials experienced pain or swelling where the shot went in. About 62% experienced fatigue, 55% got headaches and about 38% experienced muscle pains. Smaller percentages of patients experienced chills, joint pain or fever, the news report said.
Georgiou said knowing the side effects in advance can eliminate some of the concern and is a reminder that the body is responding to the vaccines and it's generating antibodies to the new agent.
She added the symptoms can be more extreme after the second dose and if they last or get worse after a day or two, a doctor should be consulted.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Are PBMs Putting GLP-1 Drugs on Their Formularies?
October 11th 2024PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is uneven. What is needed is more data about whether these drugs can lower overall healthcare costs.
Read More